Home » Topics » Regulatory » EMA

EMA
RSS

CHMP issues positive opinion on Twynsta for hypertension

July 26, 2010

EMA provides update on benefit-to-risk review of Avandia, Avandamet and Avaglim

July 26, 2010

EMA recommends restricting modafinil use

July 26, 2010

CHMP concludes topical ketoprofen has positive benefit-to-risk balance

July 23, 2010

FDA recommends further naproxcinod trials in complete response letter to NicOx

July 22, 2010

Global registrational trial announced for rFVIIIFc in hemophilia A

July 12, 2010

EMA commences review of rosiglitazone-containing medicines

July 12, 2010

E.C. approves Reyataz capsules for HIV-1 in pediatric patients

July 9, 2010

Chewable Lipitor obtains European approval for use in children

July 8, 2010

EC approves new indication for Orencia in rheumatoid arthritis

July 7, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...